Works matching IS 00071048 AND DT 2021 AND VI 192 AND IP 3

Results: 45
    1

    Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand‐1 (PD‐L1) expression and increases anti‐tumour effects of T cells in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 568, doi. 10.1111/bjh.17282
    By:
    • Chen, Haiming;
    • Li, Mingjie;
    • Ng, Nicole;
    • Yu, Erin;
    • Bujarski, Sean;
    • Yin, Zhengyi;
    • Wen, Mingxiang;
    • Hekmati, Tara;
    • Field, Dylan;
    • Wang, Jasper;
    • Nassir, Isabella;
    • Yu, Janna;
    • Huang, Justin;
    • Daniely, David;
    • Wang, Cathy S.;
    • Xu, Ning;
    • Spektor, Tanya M.;
    • Berenson, James R.
    Publication type:
    Article
    2

    Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 560, doi. 10.1111/bjh.17281
    By:
    • Strati, Paolo;
    • Cheng, Phoebe T. M.;
    • Steiner, Raphael E.;
    • Alcedo Andrade, Pedro E.;
    • Feng, Lei;
    • Sano, Dahlia;
    • Rao, Veeramaneni A.;
    • Singh, Prachee;
    • Miranda, Roberto;
    • Gunther, Jillian R.;
    • Pinnix, Chelsea C.;
    • Dabaja, Bouthaina S.;
    • Cuglievan, Branko;
    • Xing, Katharine;
    • Villa, Diego;
    • Skinnider, Brian;
    • Sehn, Laurie H.;
    • Connors, Joseph M;
    • Nieto, Yago;
    • Ahmed, Sairah
    Publication type:
    Article
    3
    4

    BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres<sup>†</sup>

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. e94, doi. 10.1111/bjh.17279
    By:
    • Ghesquières, Hervé;
    • Dalban, Cécile;
    • Nicolas‐Virelizier, Emmanuelle;
    • Jardin, Fabrice;
    • Le Bras, Fabien;
    • Le Gouill, Steven;
    • Casasnovas, Olivier;
    • Vizoso, Séraphine;
    • Hernandez, Caroline;
    • Metzger, Séverine;
    • Pérol, David;
    • Cartron, Guillaume
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. e84, doi. 10.1111/bjh.17274
    By:
    • McMillan, Annabel;
    • O'Neill, Aideen T.;
    • Townsend, William;
    • Lambert, Jonathan.;
    • Virchis, Andres;
    • Shah, Raakhee;
    • Menezes, Leon;
    • Humphries, Paul;
    • Von Both, Kirsten;
    • Grandage, Victoria;
    • Carpenter, Ben;
    • Hough, Rachael;
    • Ardeshna, Kirit M.;
    • Daw, Stephen
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    Partial response or better at six months is prognostic of superior progression‐free survival in Waldenström macroglobulinaemia patients treated with ibrutinib.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 542, doi. 10.1111/bjh.17225
    By:
    • Castillo, Jorge J.;
    • Abeykoon, Jithma P.;
    • Gustine, Joshua N.;
    • Zanwar, Saurabh;
    • Mein, Kirsten;
    • Flynn, Catherine A.;
    • Demos, Maria G.;
    • Guerrera, Maria L.;
    • Kofides, Amanda;
    • Liu, Xia;
    • Munshi, Manit;
    • Tsakmaklis, Nickolas;
    • King, Rebecca;
    • Yang, Guang;
    • Hunter, Zachary R.;
    • Advani, Ranjana H.;
    • Palomba, Maria Lia;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    22
    23
    24
    25
    26

    Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. e69, doi. 10.1111/bjh.17238
    By:
    • Turner, Gavin;
    • Smith, Madeline;
    • Hoeschen, Andrea L.;
    • Wilson, Jessica A.;
    • Kennedy, Jessica;
    • Abramson, Max;
    • Cao, Qing;
    • El Jurdi, Najla;
    • MacMillan, Margaret L.;
    • Weisdorf, Daniel J.;
    • Blazar, Bruce R.;
    • Khoruts, Alexander;
    • Shields‐Cutler, Robin R.;
    • Knights, Dan;
    • Holtan, Shernan G.;
    • Rashidi, Armin
    Publication type:
    Article
    27

    Sex differences in outcomes in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. e66, doi. 10.1111/bjh.17237
    By:
    • Derman, Benjamin A.;
    • Langerman, Spencer S.;
    • Maric, Maya;
    • Jakubowiak, Andrzej;
    • Zhang, Wei;
    • Chiu, Brian C.‐H.
    Publication type:
    Article
    28
    29
    30
    31
    32

    UK Guidelines on the Diagnosis and Treatment of Breast Implant‐Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 444, doi. 10.1111/bjh.17194
    By:
    • Turton, Philip;
    • El‐Sharkawi, Dima;
    • Lyburn, Iain;
    • Sharma, Bhupinder;
    • Mahalingam, Preethika;
    • Turner, Suzanne D.;
    • MacNeill, Fiona;
    • Johnson, Laura;
    • Hamilton, Stephen;
    • Burton, Cathy;
    • Mercer, Nigel
    Publication type:
    Article
    33

    A complication risk score to evaluate clinical severity of thalassaemia syndromes.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 626, doi. 10.1111/bjh.17203
    By:
    • Vitrano, Angela;
    • Meloni, Antonella;
    • Addario Pollina, Walter;
    • Karimi, Mehran;
    • El‐Beshlawy, Amal;
    • Hajipour, Mahmoud;
    • Di Marco, Vito;
    • Hussain Ansari, Saqib;
    • Filosa, Aldo;
    • Ricchi, Paolo;
    • Ceci, Adriana;
    • Daar, Shahina;
    • Titi Singer, Sylvia;
    • Naserullah, Zaki A.;
    • Pepe, Alessia;
    • Scondotto, Salvatore;
    • Dardanoni, Gabriella;
    • Bonifazi, Fedele;
    • Vichinsky, Elliott;
    • Maggio, Aurelio
    Publication type:
    Article
    34
    35
    36
    37

    Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 531, doi. 10.1111/bjh.16878
    By:
    • Maruyama, Dai;
    • Iida, Shinsuke;
    • Ogawa, Gakuto;
    • Fukuhara, Noriko;
    • Seo, Sachiko;
    • Miyazaki, Kana;
    • Yoshimitsu, Makoto;
    • Kuroda, Junya;
    • Tsukamoto, Norifumi;
    • Tsujimura, Hideki;
    • Hangaishi, Akira;
    • Yamauchi, Takahiro;
    • Utsumi, Takahiko;
    • Mizuno, Ishikazu;
    • Takamatsu, Yasushi;
    • Nagata, Yasuyuki;
    • Minauchi, Koichiro;
    • Ohtsuka, Eiichi;
    • Hanamura, Ichiro;
    • Yoshida, Shinichiro
    Publication type:
    Article
    38

    FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 504, doi. 10.1111/bjh.16875
    By:
    • Mikhaeel, N. George;
    • Cunningham, David;
    • Counsell, Nicholas;
    • McMillan, Andrew;
    • Radford, John A.;
    • Ardeshna, Kirit M.;
    • Lawrie, Anthony;
    • Smith, Paul;
    • Clifton‐Hadley, Laura;
    • O'Doherty, Michael J.;
    • Barrington, Sally F.
    Publication type:
    Article
    39
    40
    41

    Issue Information.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 409, doi. 10.1111/bjh.16823
    Publication type:
    Article
    42
    43

    Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 522, doi. 10.1111/bjh.16788
    By:
    • Ocio, Enrique M.;
    • Motlló, Cristina;
    • Rodríguez‐Otero, Paula;
    • Martínez‐López, Joaquín;
    • Cejalvo, Mª José;
    • Martín‐Sánchez, Jesús;
    • Bladé, Joan;
    • García‐Malo, Mª Dolores;
    • Dourdil, Mª Victoria;
    • García‐Mateo, Aránzazu;
    • Arriba, Felipe;
    • García‐Sanz, Ramón;
    • Rubia, Javier;
    • Oriol, Albert;
    • Lahuerta, Juan‐José;
    • San‐Miguel, Jesús F.;
    • Mateos, María‐Victoria
    Publication type:
    Article
    44
    45